Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001415889-25-001310

Options or other derivatives

  • CEO acquired 1,300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Wettig Thane CEO 2025-01-09 Grant or award · Stock Option (Right to Buy) +1,300,000 1,300,000 D: show line 1 in the form
Loading xslF345X05/form4-01102025_110107.xml…